ELANE and acute respiratory distress syndrome: A recent study reported benzenesulfonic acid derivatives as human neutrophil elastase inhibitors to treat acute respiratory distress syndrome [32]; however, there is still no research related to the tumour metabolic pathways involving benzenesulfonic acids.